Back to Search
JENNIFER MAYA, MD
MD
Family Medicine Physician
NPI: 1518161686IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
11013641A(IN)
CMS Specialties
PrimaryFAMILY PRACTICE
Education
INDIANA UNIVERSITY SCHOOL OF MEDICINE
Class of 2006
Research & Publications (20)
Mode of action of natural and synthetic drugs against Trypanosoma cruzi and their interaction with the mammalian host.
PMID 16626984·Comp Biochem Physiol A Mol Integr Physiol·2007
6-review
Effects of buthionine sulfoximine nifurtimox and benznidazole upon trypanothione and metallothionein proteins in Trypanosoma cruzi.
PMID 15174306·Biol Res·2004
7-preclinical
Trypanosoma cruzi: effect and mode of action of nitroimidazole and nitrofuran derivatives.
PMID 12623132·Biochem Pharmacol·2003
7-preclinical
Trypanosoma cruzi: inhibition of parasite growth and respiration by oxazolo(thiazolo)pyridine derivatives and its relationship to redox potential and lipophilicity.
PMID 11708828·Exp Parasitol·2001
7-preclinical
Effects of albumin/furosemide mixtures on responses to furosemide in hypoalbuminemic patients.
PMID 11316860·J Am Soc Nephrol·2001
8-other
Effects of 3-chloro-phenyl-1,4-dihydropyridine derivatives on Trypanosome cruzi epimastigotes.
PMID 11790334·Comp Biochem Physiol C Toxicol Pharmacol·2000
7-preclinical
Plasmodium falciparum: effect of Solanum nudum steroids on thiol contents and beta-hematin formation in parasitized erythrocytes.
PMID 19442662·Exp Parasitol·2009
7-preclinical
Study of 5-nitroindazoles' anti-Trypanosoma cruzi mode of action: electrochemical behaviour and ESR spectroscopic studies.
PMID 18762357·Eur J Med Chem·2009
7-preclinical
In vitro and in vivo antitrypanosomatid activity of 5-nitroindazoles.
PMID 18706738·Eur J Med Chem·2009
7-preclinical
Buthionine sulfoximine has anti-Trypanosoma cruzi activity in a murine model of acute Chagas' disease and enhances the efficacy of nifurtimox.
PMID 18332173·Antimicrob Agents Chemother·2008
7-preclinical
Insight into the bioreductive mode of action of antitrypanosomal 5-nitrofuryl containing thiosemicarbazones.
PMID 18220967·Med Chem·2008
7-preclinical
Trypanosoma cruzi: activities of lapachol and alpha- and beta-lapachone derivatives against epimastigote and trypomastigote forms.
PMID 18029184·Bioorg Med Chem·2008
7-preclinical
Nitrofurylsemicarbazone rhenium and ruthenium complexes as anti-trypanosomal agents.
PMID 16828524·Eur J Med Chem·2006
7-preclinical
Novel antitrypanosomal agents based on palladium nitrofurylthiosemicarbazone complexes: DNA and redox metabolism as potential therapeutic targets.
PMID 16722651·J Med Chem·2006
7-preclinical
Indazole N-oxide derivatives as antiprotozoal agents: synthesis, biological evaluation and mechanism of action studies.
PMID 16483783·Bioorg Med Chem·2006
7-preclinical
Buthionine sulfoximine increases the toxicity of nifurtimox and benznidazole to Trypanosoma cruzi.
PMID 15616285·Antimicrob Agents Chemother·2005
7-preclinical
Alterations of rat liver mitochondrial oxidative phosphorylation and calcium uptake by benzo[a]pyrene.
PMID 15207643·Toxicol Appl Pharmacol·2004
7-preclinical
Differential induction of apoptosis and necrosis in monocytes from patients with tuberculosis and healthy control subjects.
PMID 15143481·J Infect Dis·2004
8-other
Synthesis of dihydronaphthofurandiones and dihydrofuroquinolinediones with trypanocidal activity and analysis of their stereoelectronic properties.
PMID 15080940·Bioorg Med Chem·2004
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1001 STURDY RD
VALPARAISO, IN 46383 - Phone
- (219) 462-7173
Quick Facts
- NPI
- 1518161686
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 20
- Publications
- 20
Are you this provider?
Claim Your Profile